Form 4: Clover Health CFO Peter Kuipers Reports Acquisition of Restricted Stock Units

Clover Health's CFO, Peter Kuipers, reports the acquisition of restricted stock units (RSUs) that will vest over time, according to a Form 4 filing.

Summary

• Peter Kuipers, the Chief Financial Officer of Clover Health Investments, Corp., filed a Form 4 detailing changes in beneficial ownership.
• On May 19, 2025, Kuipers acquired 326,647 shares of Class A Common Stock through a restricted stock unit (RSU) award.
• The price of the stock at the time of acquisition was $0.
• Following the transaction, Kuipers beneficially owns 6,349,973 shares of Class A Common Stock directly.
• The RSUs vest over time, with 25% vesting on the first anniversary of May 19, 2025, and the remaining RSUs vesting in twelve equal quarterly installments thereafter, contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by the CFO is a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by the CFO demonstrates confidence in the company's future performance.
• The vesting schedule incentivizes the CFO to remain with the company.

Future Outlook

The vesting schedule of the RSUs suggests a long-term commitment from the CFO to the company's success.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates the CFO's continued stake in Clover Health.

Stakeholder Impact

• The vesting schedule of the RSUs aligns the CFO's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates

Keywords

Form 4, Clover Health, Peter Kuipers, CFO, RSU, Restricted Stock Units, Beneficial Ownership, Class A Common Stock, Vesting